These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31126662)

  • 21. Clonal Hematopoiesis of Indeterminate Potential.
    Heuser M; Thol F; Ganser A
    Dtsch Arztebl Int; 2016 May; 113(18):317-22. PubMed ID: 27215596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal Hematopoiesis-Associated Gene Mutations Affect Acute Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation in AML Patients.
    Wei X; Huang S; Gu Z; Liu J; Li M; Jin X; Bo J; Li F; Jing Y; Gao X; Dou L; Liu D; Gao C
    Ann Transplant; 2024 Jul; 29():e943688. PubMed ID: 38952007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
    Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U
    Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural history of clonal haematopoiesis seen in real-world haematology settings.
    Patel SA; Gerber WK; Zheng R; Khanna S; Hutchinson L; Abel GA; Cerny J; DaSilva BA; Zhang TY; Ramanathan M; Khedr S; Selove W; Woda B; Miron PM; Higgins AW; Gerber JM
    Br J Haematol; 2024 May; 204(5):1844-1855. PubMed ID: 38522849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of Mutation Profiling in Myeloid Malignancies-PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia.
    Tremblay D; Sokol K; Bhalla S; Rampal R; Mascarenhas JO
    Oncology (Williston Park); 2018 Apr; 32(4):e38-e44. PubMed ID: 29684235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic Value of DTA Mutations in Patients with Newly Diagnosed Acute Myeloid Leukemia].
    Chen HJ; Cao Y; Miao YJ; Zhou YF; Liu Y; Gu WY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):993-998. PubMed ID: 39192388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clonal haematopoiesis is increased in early onset in systemic sclerosis.
    Ricard L; Hirsch P; Largeaud L; Deswarte C; Jachiet V; Mohty M; Rivière S; Malard F; Tenon M; de Vassoigne F; Fain O; Gaugler B; Rossignol J; Delhommeau F; Mekinian A;
    Rheumatology (Oxford); 2020 Nov; 59(11):3499-3504. PubMed ID: 32757002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1.
    Saadatagah S; Naderian M; Uddin M; Dikilitas O; Niroula A; Schuermans A; Selvin E; Hoogeveen RC; Matsushita K; Nambi V; Yu B; Chen LY; Bick AG; Ebert BL; Honigberg MC; Li N; Shah A; Natarajan P; Kullo IJ; Ballantyne CM
    JAMA Cardiol; 2024 Jun; 9(6):497-506. PubMed ID: 38598228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
    Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
    Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
    Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
    Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
    Jentzsch M; Grimm J; Bill M; Küpper J; Backhaus D; Brauer D; Schulz J; Franke GN; Vucinic V; Niederwieser D; Platzbecker U; Schwind S
    Bone Marrow Transplant; 2021 Oct; 56(10):2610-2612. PubMed ID: 34267355
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical consequences of clonal hematopoiesis of indeterminate potential.
    Steensma DP
    Blood Adv; 2018 Nov; 2(22):3404-3410. PubMed ID: 30482770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epigenetic dysregulation in myelodysplastic syndromes].
    Sashida G
    Rinsho Ketsueki; 2017; 58(10):1809-1817. PubMed ID: 28978819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis.
    Saiki R; Momozawa Y; Nannya Y; Nakagawa MM; Ochi Y; Yoshizato T; Terao C; Kuroda Y; Shiraishi Y; Chiba K; Tanaka H; Niida A; Imoto S; Matsuda K; Morisaki T; Murakami Y; Kamatani Y; Matsuda S; Kubo M; Miyano S; Makishima H; Ogawa S
    Nat Med; 2021 Jul; 27(7):1239-1249. PubMed ID: 34239136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Genome-wide analysis of AML and MDS].
    Ogawa S
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():113-8. PubMed ID: 23133938
    [No Abstract]   [Full Text] [Related]  

  • 37. Somatic Mutations and Clonal Hematopoiesis: Unexpected Potential New Drivers of Age-Related Cardiovascular Disease.
    Fuster JJ; Walsh K
    Circ Res; 2018 Feb; 122(3):523-532. PubMed ID: 29420212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis.
    Traina F; Visconte V; Jankowska AM; Makishima H; O'Keefe CL; Elson P; Han Y; Hsieh FH; Sekeres MA; Mali RS; Kalaycio M; Lichtin AE; Advani AS; Duong HK; Copelan E; Kapur R; Olalla Saad ST; Maciejewski JP; Tiu RV
    PLoS One; 2012; 7(8):e43090. PubMed ID: 22905207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-Associated
    Ferrone CK; Blydt-Hansen M; Rauh MJ
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.